Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Neovasc is a leader in the development of minimally invasive therapies for two of the most vexing challenges in cardiovascular care: refractory angina and mitral valve regurgitation. The company is committed to clinical rigor and collaborates with researchers and clinicians in Canada, the United States, Europe, and the Middle East. Our products, the Reducer™ and Tiara™ systems, represent the forefront of innovation in t...
Neovasc is a leader in the development of minimally invasive therapies for two of the most vexing challenges in cardiovascular care: refractory angina and mitral valve regurgitation. The company is committed to clinical rigor and collaborates with researchers and clinicians in Canada, the United States, Europe, and the Middle East. Our products, the Reducer™ and Tiara™ systems, represent the forefront of innovation in treating advanced heart disease. Reducer is CE-marked for use in the EU and is FDA approved for investigational use in the US.

List your booth number for exhibitions, ask us

Contact Neovasc and get a quotation

Neovasc is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Hydrochloric Acid bulk with JDMF offered by Neovasc

Find a price of Bovine Serum bulk offered by Neovasc